| Dr Madhu Menon, MD | |
|
300 Bretz Ct Ste 100, Newport, PA 17074-8615 | |
| (717) 567-3174 | |
| (717) 703-0018 |
| Full Name | Dr Madhu Menon |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 46 Years |
| Location | 300 Bretz Ct Ste 100, Newport, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396706131 | NPI | - | NPPES |
| 001692743 | Medicaid | PA | |
| 1136775 | Other | PA | FIRST HEALTH |
| P967510 | Other | PA | GATEWAY |
| 0228002 | Other | PA | KEYSTONE |
| 080137007 | Other | PA | RAIL ROAD MEDICARE |
| 860303 | Other | PA | AETNA |
| ME967510 | Other | PA | HIGHMARK BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD061440L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Grane Hospice Care | Lemoyne, PA | Hospice |
| Holy Spirit Hospital | Camp hill, PA | Hospital |
| Pinnacle Health Hospitals | Harrisburg, PA | Hospital |
| St Joseph Medical Center | Reading, PA | Hospital |
| Kinkora Pythian Home | Duncannon, PA | Nursing home |
| Jewish Home Of Greater Harrisb | Harrisburg, PA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pinnacle Health Medical Services | 7618960493 | 942 |
News Archive
The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases.
Alcohol consumption may slightly increase the risk for developing a certain type of irregular heart beat, known as atrial fibrillation, or atrial flutter, according to an article in the October 11 issue of The Archives of Internal Medicine.
University of York spinout company, Cizzle Biotechnology, has secured venture capital funding from the White Rose Technology Seedcorn Fund to continue its development of a potential new diagnostic test and treatment for lung cancer.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
› Verified 4 days ago
| Entity Name | Pinnacle Health Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932143427 PECOS PAC ID: 7618960493 Enrollment ID: O20040407000180 |
News Archive
The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases.
Alcohol consumption may slightly increase the risk for developing a certain type of irregular heart beat, known as atrial fibrillation, or atrial flutter, according to an article in the October 11 issue of The Archives of Internal Medicine.
University of York spinout company, Cizzle Biotechnology, has secured venture capital funding from the White Rose Technology Seedcorn Fund to continue its development of a potential new diagnostic test and treatment for lung cancer.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Madhu Menon, MD 300 Bretz Ct Ste 100, Newport, PA 17074-8615 Ph: (717) 567-3174 | Dr Madhu Menon, MD 300 Bretz Ct Ste 100, Newport, PA 17074-8615 Ph: (717) 567-3174 |
News Archive
The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases.
Alcohol consumption may slightly increase the risk for developing a certain type of irregular heart beat, known as atrial fibrillation, or atrial flutter, according to an article in the October 11 issue of The Archives of Internal Medicine.
University of York spinout company, Cizzle Biotechnology, has secured venture capital funding from the White Rose Technology Seedcorn Fund to continue its development of a potential new diagnostic test and treatment for lung cancer.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
› Verified 4 days ago
Michael Andrew Thieblemont, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 46 Red Hill Ct, Newport, PA 17074 Phone: 717-567-3151 Fax: 717-567-7571 | |
Michelle Liane Brenizer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 46 Red Hill Ct, Newport, PA 17074 Phone: 717-567-3151 Fax: 717-567-7571 | |
Dr. Kendra M Davis, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Bretz Ct Ste 100, Newport, PA 17074 Phone: 717-567-3174 Fax: 717-703-0018 | |
Albert Bauer Knouse Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 46 Red Hill Ct, Newport, PA 17074 Phone: 717-567-3151 Fax: 717-567-7571 |